- Home
- BCTX
as 04-04-2025 4:00pm EST
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
| Founded: | 2014 | Country: | Canada |
| Employees: | N/A | City: | WEST VANCOUVER |
| Market Cap: | 15.8M | IPO Year: | N/A |
| Target Price: | $32.00 | AVG Volume (30 days): | 44.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.35 - $7.87 | Next Earning Date: | 03-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BriaCell Therapeutics Corp. News
BCTX Breaking Stock News: Dive into BCTX Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
MT Newswires
17 days ago
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer
GlobeNewswire
17 days ago
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer
Zacks
2 months ago
BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
GlobeNewswire
2 months ago
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
GlobeNewswire
2 months ago
BriaCell Therapeutics Announces Closing of Public Offering
Zacks
2 months ago
BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?
MT Newswires
2 months ago
Top Premarket Decliners
Compare BCTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BCTX BriaCell Therapeutics Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.